HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RNA Virus Infections

Diseases caused by RNA VIRUSES.
Also Known As:
Infections, RNA Virus; Infection, RNA Virus; RNA Virus Infection; Virus Infection, RNA; Virus Infections, RNA
Networked: 303 relevant articles (3 outcomes, 15 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infections
2. Human Influenza (Influenza)
3. Communicable Diseases (Infectious Diseases)
4. Bites and Stings (Sting)
5. Virus Diseases (Viral Diseases)

Experts

1. Gale, Michael: 6 articles (01/2019 - 01/2007)
2. Lin, Rongtuan: 6 articles (01/2017 - 06/2006)
3. Hiscott, John: 6 articles (08/2015 - 06/2006)
4. Matsumoto, Misako: 6 articles (02/2014 - 10/2007)
5. Seya, Tsukasa: 6 articles (02/2014 - 10/2007)
6. Akira, Shizuo: 5 articles (01/2010 - 07/2006)
7. Takeuchi, Osamu: 5 articles (01/2010 - 07/2006)
8. Horner, Stacy M: 4 articles (12/2022 - 01/2015)
9. Kumar, Himanshu: 4 articles (11/2020 - 07/2006)
10. Jung, Jae U: 4 articles (01/2018 - 04/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to RNA Virus Infections:
1. Viral RNAIBA
2. favipiravirIBA
3. Attenuated VaccinesIBA
4. DNA-Directed RNA Polymerases (RNA Polymerase)IBA
5. remdesivirIBA
6. Antiviral Agents (Antivirals)IBA
7. Proteins (Proteins, Gene)FDA Link
8. DNA (Deoxyribonucleic Acid)IBA
9. MicroRNAs (MicroRNA)IBA
10. NucleosidesIBA
01/01/2018 - "Nucleosides for the treatment of respiratory RNA virus infections."
01/01/2019 - "In cell culture studies and with laboratory animal models, the nucleoside analogue favipiravir (T-705) has demonstrated great potential for the treatment of several seasonal, chronic, and emerging RNA virus infections in humans, suggesting applicability to control some viral outbreaks. "
08/20/2004 - "Ribavirin is one of the few nucleoside analogues currently used in the clinic to treat RNA virus infections, but its mechanism of action remains poorly understood at the molecular level. "
01/01/2003 - "We speculate that incorporated nucleoside analogues with the capacity of changing the thermodynamics of regulatory secondary structures (with or without introducing mutations) may represent an important class of new antiviral agents for the treatment of RNA virus infections, especially HCV."
04/01/2002 - "This includes, for the treatment of HIV infections, virus adsorption inhibitors (cosalane derivatives, cyanovirin-N), co-receptor antagonists (TAK-779, AMD3100), viral fusion inhibitors (pentafuside T-20, betulinic acid derivatives), viral uncoating inhibitors (azodicarbonamide), nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs: emtricitabine, amdoxovir, dOTC, d4TMP prodrugs, tenofovir disoproxil fumarate), non-nucleoside reverse transcriptase inhibitors (NNRTIs: thiocarboxanilide UC-781, capravirine, SJ-3366, DPC 083, TMC 125/R165335), integrase inhibitors (diketo acids), transcription inhibitors (temacrazine, flavopiridol), protease inhibitors (atazanavir, mozenavir, tipranavir); for the treatment of RSV and paramyxovirus infections, viral fusion inhibitors (R170591, VP-14637, NMS03); for the treatment of picornavirus infections, viral uncoating inhibitors (pleconaril); for the treatment of pesti- (hepaci-, flavi-) virus infections, RNA replicase inhibitors (VP-32947); for the treatment of herpesvirus (HSV, VZV, CMV) infections, DNA polymerase inhibitors (A-5021, L- and D-cyclohexenylguanine); for the treatment of VZV infections, bicyclic furopyrimidine analogues; for the treatment of CMV infections, fomivirsen; for the treatment of DNA virus infections at large (papilloma-, polyoma-, herpes-, adeno- and poxvirus infections), cidofovir; for the treatment of influenza, neuraminidase inhibitors (zanamivir, oseltamivir, RWJ-270201); for the treatment of HBV infections, adefovir dipivoxil; for the treatment of HBV and HCV infections, N-glycosylation inhibitors (N-nonyl-deoxynojirimycin); and, finally, IMP dehydrogenase inhibitors and S-adenosylhomocysteine hydrolase inhibitors, for the treatment of various virus infections, including hemorrhagic fever virus infections."

Therapies and Procedures

1. Therapeutics
2. Surgical Instruments (Clip)
3. Immunotherapy
4. Drug Therapy (Chemotherapy)